Estimating the influence of rescreening interval on the benefits associated with cancer screening

Approaches and limitations

Noel S. Weiss, Ruth Etzioni

Research output: Contribution to journalReview article

16 Citations (Scopus)

Abstract

Randomized controlled trials that seek to measure the ability of a screening test to lower cancer mortality generally do not provide data that bear on the relative efficacy of different screening intervals. Guidance regarding the choice of a screening interval that achieves a high level of case-finding, without being excessively costly, can be obtained from one or more of several study designs that examine the subsequent occurrence of cancer in persons who have had a negative screening test. However, each of these can potentially provide a misleading result, and so their limitations must be considered before using the data they generate to develop a rational rescreening policy.

Original languageEnglish (US)
Pages (from-to)713-717
Number of pages5
JournalEpidemiology
Volume13
Issue number6
DOIs
StatePublished - Nov 1 2002
Externally publishedYes

Fingerprint

Early Detection of Cancer
Neoplasms
Randomized Controlled Trials
Mortality

ASJC Scopus subject areas

  • Epidemiology

Cite this

Estimating the influence of rescreening interval on the benefits associated with cancer screening : Approaches and limitations. / Weiss, Noel S.; Etzioni, Ruth.

In: Epidemiology, Vol. 13, No. 6, 01.11.2002, p. 713-717.

Research output: Contribution to journalReview article

@article{01a7aac0e5684cd8b47da8b6cd446e4c,
title = "Estimating the influence of rescreening interval on the benefits associated with cancer screening: Approaches and limitations",
abstract = "Randomized controlled trials that seek to measure the ability of a screening test to lower cancer mortality generally do not provide data that bear on the relative efficacy of different screening intervals. Guidance regarding the choice of a screening interval that achieves a high level of case-finding, without being excessively costly, can be obtained from one or more of several study designs that examine the subsequent occurrence of cancer in persons who have had a negative screening test. However, each of these can potentially provide a misleading result, and so their limitations must be considered before using the data they generate to develop a rational rescreening policy.",
author = "Weiss, {Noel S.} and Ruth Etzioni",
year = "2002",
month = "11",
day = "1",
doi = "10.1097/00001648-200211000-00017",
language = "English (US)",
volume = "13",
pages = "713--717",
journal = "Epidemiology",
issn = "1044-3983",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Estimating the influence of rescreening interval on the benefits associated with cancer screening

T2 - Approaches and limitations

AU - Weiss, Noel S.

AU - Etzioni, Ruth

PY - 2002/11/1

Y1 - 2002/11/1

N2 - Randomized controlled trials that seek to measure the ability of a screening test to lower cancer mortality generally do not provide data that bear on the relative efficacy of different screening intervals. Guidance regarding the choice of a screening interval that achieves a high level of case-finding, without being excessively costly, can be obtained from one or more of several study designs that examine the subsequent occurrence of cancer in persons who have had a negative screening test. However, each of these can potentially provide a misleading result, and so their limitations must be considered before using the data they generate to develop a rational rescreening policy.

AB - Randomized controlled trials that seek to measure the ability of a screening test to lower cancer mortality generally do not provide data that bear on the relative efficacy of different screening intervals. Guidance regarding the choice of a screening interval that achieves a high level of case-finding, without being excessively costly, can be obtained from one or more of several study designs that examine the subsequent occurrence of cancer in persons who have had a negative screening test. However, each of these can potentially provide a misleading result, and so their limitations must be considered before using the data they generate to develop a rational rescreening policy.

UR - http://www.scopus.com/inward/record.url?scp=0036832442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036832442&partnerID=8YFLogxK

U2 - 10.1097/00001648-200211000-00017

DO - 10.1097/00001648-200211000-00017

M3 - Review article

VL - 13

SP - 713

EP - 717

JO - Epidemiology

JF - Epidemiology

SN - 1044-3983

IS - 6

ER -